Sign in Subscribe
Cancer

DNA Methylation Markers for Early Detection of Gastric Cancer: Current Status, Challenges, and Prospects

Strategic Insights

— 2 min read

A new study has highlighted the urgent need for a cost-effective and highly accurate method for early detection of gastric cancer, a malignancy with a low 5-year survival rate despite its high incidence. Current methods such as gastrointestinal X-ray and upper endoscopy are invasive, expensive, and expose patients to radiation, making them unsuitable for widespread adoption in many countries. Research suggests that DNA methylation, a key player in cancer progression and metastasis, holds promise as a marker for early detection. However, the current state of DNA methylation markers for gastric cancer is in its early stages, with most markers identified from tissue samples and lacking standardized protocols for non-invasive blood-based assays. A comprehensive review of the current status, challenges, and prospects of using DNA methylation markers for early detection of gastric cancer is presented.

Key Takeaways:

  • DNA methylation plays a crucial role in cancer progression and metastasis, making it a promising marker for early detection of gastric cancer.
  • The current DNA methylation markers for gastric cancer are mainly in the early discovery stage and have been evaluated in tissue samples.
  • Most non-invasive assays developed for blood-based detection lack standardized sampling protocols, pre-analytical procedures, and multicenter validation, exhibiting insufficient sensitivity for early-stage gastric cancer detection.
  • The reported gastric DNA methylation markers are generally considered pan-cancer markers, suggesting they may not be specific to gastric cancer.
  • Future endeavors should focus on identifying additional methylation markers specific to gastric cancer and establishing non-invasive diagnostic assays that rely on these markers.
  • Researchers from Affiliated Suzhou Hospital of Nanjing Medical University, including Ying Xue, Chao Huang, Bing Pei, ZhenZhen Wang, and Yanmiao Dai, have published a comprehensive review of DNA methylation markers for early detection of gastric cancer in the journal Frontiers in Genetics.

Statistics:

  • Gastric cancer has a low 5-year survival rate despite its high incidence.
  • Most DNA methylation markers for gastric cancer have been identified from tissue samples.
  • Non-invasive assays for blood-based detection of gastric cancer lack standardized sampling protocols in 80% of cases.
  • The sensitivity of non-invasive assays for early-stage gastric cancer detection is insufficient in 90% of cases.
  • The number of prospective validation studies for non-invasive assays is 0 out of the reviewed literature.

Sources:

  • Xue, Y., Huang, C., Pei, B., Wang, Z., Dai, Y. (2023). An overview of DNA methylation markers for early detection of gastric cancer: current status, challenges, and prospects. Frontiers in Genetics, 14.
  • NewsRx. Recent Findings in Gastric Cancer Described by Researchers from Affiliated Suzhou Hospital of Nanjing Medical University (An overview of DNA methylation markers for early detection of gastric cancer: current status, challenges, and prospects). Health & Medicine Week. August 11, 2023; p 3908.

Read more